Jump to content
Wikipedia The Free Encyclopedia

ACE inhibitor and thiazide combination

From Wikipedia, the free encyclopedia
A combination of antihypertensive drugs used to treat hypertension

An ACE inhibitor and thiazide combination is a drug combination used to treat hypertension (high blood pressure). They are given by mouth. ACE inhibitors reduce the activity of angiotensin-converting enzyme (ACE) which produces angiotensin II, a hormone that constricts blood vessels. Thiazides are a class of diuretics that inhibit the thiazide receptor, thereby increasing urine production and reducing excess water and salt in the body. Several organizations recommend combination therapy for hypertension in cases of failure of a single drug to achieve target blood pressure, or even as a first line treatment for some patients.[1]

Examples

[edit ]
Pharmaceutical compound
Quinapril/hydrochlorothiazide
Combination of
Quinapril Angiotensin converting enzyme inhibitor
Hydrochlorothiazide Thiazide diuretic
Clinical data
Trade names Accuretic
AHFS/Drugs.com Multum Consumer Information
ATC code
Legal status
Legal status
Identifiers
ChemSpider
KEGG
Pharmaceutical compound
Lisinopril/hydrochlorothiazide
Combination of
Lisinopril ACE inhibitor
Hydrochlorothiazide Thiazide diuretic
Clinical data
MedlinePlus a601070
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
KEGG
  (verify)

Fosinopril/hydrochlorothiazide

[edit ]
Pharmaceutical compound
Fosinopril/hydrochlorothiazide
Combination of
Fosinopril Angiotensin converting enzyme inhibitor
Hydrochlorothiazide Thiazide diuretic
Clinical data
Trade names Monopril HCT
Pregnancy
category
  • C (1st trimester); D (2nd & 3rd trimesters)
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)

Fosinopril/hydrochlorothiazide (trade name Monopril HCT) has a boxed warning about its risk to cause morbidity and mortality in the baby when being used during pregnancy (second and third trimesters).[5]

The FDA modified its labeling in February 2009 to include a precaution of drug interaction with gold. "Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including Monopril/Monopril HCT."[6]

See also

[edit ]

References

[edit ]
ACE inhibitors
("-pril")
AIIRAs
("-sartan")
Renin inhibitors
("-kiren")
Dual ACE/NEP inhibitors
Neprilysin inhibitors
Other

AltStyle によって変換されたページ (->オリジナル) /